Additionally, tumor burden, generally represented by the number of metastatic lesions or tumor size, has been reported to predict the efficacy and survival of PD‐1/PD‐L1‐treated patients with various tumor types.17, 18, 19, 20, 21. The gene discussed is CD274; the disease is neoplasm.